nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—atherosclerosis	0.00131	0.00435	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—EDNRA—atherosclerosis	0.0013	0.00431	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCR2—atherosclerosis	0.0013	0.00431	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—GHRL—atherosclerosis	0.00127	0.0042	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.00126	0.00419	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—UTS2—atherosclerosis	0.00126	0.00416	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—EDN1—atherosclerosis	0.00124	0.00412	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.00123	0.00408	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.00122	0.00404	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CX3CR1—atherosclerosis	0.0012	0.00399	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CASR—atherosclerosis	0.0012	0.00399	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CX3CL1—atherosclerosis	0.00118	0.00391	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—atherosclerosis	0.00117	0.00387	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.00114	0.00379	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.00114	0.00379	CbGpPWpGaD
Goserelin—Infection—Rosuvastatin—atherosclerosis	0.00113	0.00162	CcSEcCtD
Goserelin—Alopecia—Simvastatin—atherosclerosis	0.00112	0.00161	CcSEcCtD
Goserelin—Back pain—Ezetimibe—atherosclerosis	0.00112	0.00161	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—CNR2—atherosclerosis	0.00112	0.00371	CbGpPWpGaD
Goserelin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00112	0.0016	CcSEcCtD
Goserelin—Muscle spasms—Ezetimibe—atherosclerosis	0.00112	0.0016	CcSEcCtD
Goserelin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00112	0.0016	CcSEcCtD
Goserelin—Vision blurred—Lovastatin—atherosclerosis	0.00112	0.0016	CcSEcCtD
Goserelin—Mental disorder—Simvastatin—atherosclerosis	0.00111	0.0016	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.00111	0.00369	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.00111	0.00369	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—KNG1—atherosclerosis	0.00111	0.00368	CbGpPWpGaD
Goserelin—Erythema—Simvastatin—atherosclerosis	0.00111	0.00159	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—AGTR1—atherosclerosis	0.00111	0.00366	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—HRH1—atherosclerosis	0.0011	0.00365	CbGpPWpGaD
Goserelin—Ill-defined disorder—Lovastatin—atherosclerosis	0.0011	0.00157	CcSEcCtD
Goserelin—Eye disorder—Niacin—atherosclerosis	0.00109	0.00156	CcSEcCtD
Goserelin—Flatulence—Simvastatin—atherosclerosis	0.00109	0.00156	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CCL4—atherosclerosis	0.00108	0.00358	CbGpPWpGaD
Goserelin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00108	0.00154	CcSEcCtD
Goserelin—Anaemia—Ezetimibe—atherosclerosis	0.00107	0.00154	CcSEcCtD
Goserelin—Malaise—Lovastatin—atherosclerosis	0.00107	0.00153	CcSEcCtD
Goserelin—Cardiac disorder—Pravastatin—atherosclerosis	0.00107	0.00153	CcSEcCtD
Goserelin—Muscle spasms—Simvastatin—atherosclerosis	0.00106	0.00152	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—UTS2—atherosclerosis	0.00106	0.00351	CbGpPWpGaD
Goserelin—Angiopathy—Niacin—atherosclerosis	0.00106	0.00152	CcSEcCtD
Goserelin—Leukopenia—Lovastatin—atherosclerosis	0.00106	0.00152	CcSEcCtD
Goserelin—Chills—Niacin—atherosclerosis	0.00105	0.0015	CcSEcCtD
Goserelin—Malaise—Ezetimibe—atherosclerosis	0.00105	0.0015	CcSEcCtD
Goserelin—Vision blurred—Simvastatin—atherosclerosis	0.00104	0.00149	CcSEcCtD
Goserelin—Arrhythmia—Niacin—atherosclerosis	0.00104	0.00149	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00104	0.00149	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—AGT—atherosclerosis	0.00103	0.00342	CbGpPWpGaD
Goserelin—Alopecia—Niacin—atherosclerosis	0.00103	0.00148	CcSEcCtD
Goserelin—Chills—Pravastatin—atherosclerosis	0.00103	0.00148	CcSEcCtD
Goserelin—Insomnia—Rosuvastatin—atherosclerosis	0.00103	0.00148	CcSEcCtD
Goserelin—Ill-defined disorder—Simvastatin—atherosclerosis	0.00103	0.00147	CcSEcCtD
Goserelin—Arrhythmia—Pravastatin—atherosclerosis	0.00103	0.00147	CcSEcCtD
Goserelin—Palpitations—Ezetimibe—atherosclerosis	0.00103	0.00147	CcSEcCtD
Goserelin—Paraesthesia—Rosuvastatin—atherosclerosis	0.00102	0.00147	CcSEcCtD
Goserelin—Anaemia—Simvastatin—atherosclerosis	0.00102	0.00147	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00102	0.00338	CbGpPWpGaD
Goserelin—Erythema—Niacin—atherosclerosis	0.00102	0.00146	CcSEcCtD
Goserelin—Malnutrition—Niacin—atherosclerosis	0.00102	0.00146	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—CASR—atherosclerosis	0.00102	0.00337	CbGpPWpGaD
Goserelin—Alopecia—Pravastatin—atherosclerosis	0.00102	0.00145	CcSEcCtD
Goserelin—Cough—Ezetimibe—atherosclerosis	0.00101	0.00145	CcSEcCtD
Goserelin—Chest pain—Lovastatin—atherosclerosis	0.00101	0.00144	CcSEcCtD
Goserelin—Myalgia—Lovastatin—atherosclerosis	0.00101	0.00144	CcSEcCtD
Goserelin—Arthralgia—Lovastatin—atherosclerosis	0.00101	0.00144	CcSEcCtD
Goserelin—Anxiety—Lovastatin—atherosclerosis	0.001	0.00144	CcSEcCtD
Goserelin—Dyspepsia—Rosuvastatin—atherosclerosis	0.001	0.00144	CcSEcCtD
Goserelin—Hypertension—Ezetimibe—atherosclerosis	0.001	0.00144	CcSEcCtD
Goserelin—Flatulence—Niacin—atherosclerosis	0.001	0.00143	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—HRH1—atherosclerosis	0.001	0.00331	CbGpPWpGaD
Goserelin—Malaise—Simvastatin—atherosclerosis	0.000998	0.00143	CcSEcCtD
Goserelin—Tension—Niacin—atherosclerosis	0.000997	0.00143	CcSEcCtD
Goserelin—Discomfort—Lovastatin—atherosclerosis	0.000995	0.00143	CcSEcCtD
Goserelin—Leukopenia—Simvastatin—atherosclerosis	0.000991	0.00142	CcSEcCtD
Goserelin—Chest pain—Ezetimibe—atherosclerosis	0.000988	0.00142	CcSEcCtD
Goserelin—Arthralgia—Ezetimibe—atherosclerosis	0.000988	0.00142	CcSEcCtD
Goserelin—Myalgia—Ezetimibe—atherosclerosis	0.000988	0.00142	CcSEcCtD
Goserelin—Nervousness—Niacin—atherosclerosis	0.000987	0.00141	CcSEcCtD
Goserelin—Flatulence—Pravastatin—atherosclerosis	0.000986	0.00141	CcSEcCtD
Goserelin—Dry mouth—Lovastatin—atherosclerosis	0.000985	0.00141	CcSEcCtD
Goserelin—Tension—Pravastatin—atherosclerosis	0.000982	0.00141	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000981	0.00141	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000977	0.00324	CbGpPWpGaD
Goserelin—Muscle spasms—Niacin—atherosclerosis	0.000977	0.0014	CcSEcCtD
Goserelin—Discomfort—Ezetimibe—atherosclerosis	0.000976	0.0014	CcSEcCtD
Goserelin—Constipation—Rosuvastatin—atherosclerosis	0.000974	0.0014	CcSEcCtD
Goserelin—Pain—Rosuvastatin—atherosclerosis	0.000974	0.0014	CcSEcCtD
Goserelin—Confusional state—Lovastatin—atherosclerosis	0.000974	0.00139	CcSEcCtD
Goserelin—Nervousness—Pravastatin—atherosclerosis	0.000972	0.00139	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000972	0.00322	CbGpPWpGaD
Goserelin—Dry mouth—Ezetimibe—atherosclerosis	0.000966	0.00138	CcSEcCtD
Goserelin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000966	0.00138	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—UTS2—atherosclerosis	0.000962	0.00319	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL3—atherosclerosis	0.000962	0.00319	CbGpPWpGaD
Goserelin—Muscle spasms—Pravastatin—atherosclerosis	0.000962	0.00138	CcSEcCtD
Goserelin—Infection—Lovastatin—atherosclerosis	0.000959	0.00137	CcSEcCtD
Goserelin—Vision blurred—Niacin—atherosclerosis	0.000958	0.00137	CcSEcCtD
Goserelin—Confusional state—Ezetimibe—atherosclerosis	0.000955	0.00137	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—F2—atherosclerosis	0.000954	0.00316	CbGpPWpGaD
Goserelin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000947	0.00136	CcSEcCtD
Goserelin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000945	0.00135	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—CNR2—atherosclerosis	0.000945	0.00313	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000944	0.00313	CbGpPWpGaD
Goserelin—Vision blurred—Pravastatin—atherosclerosis	0.000943	0.00135	CcSEcCtD
Goserelin—Chest pain—Simvastatin—atherosclerosis	0.000942	0.00135	CcSEcCtD
Goserelin—Myalgia—Simvastatin—atherosclerosis	0.000942	0.00135	CcSEcCtD
Goserelin—Arthralgia—Simvastatin—atherosclerosis	0.000942	0.00135	CcSEcCtD
Goserelin—Infection—Ezetimibe—atherosclerosis	0.000941	0.00135	CcSEcCtD
Goserelin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000939	0.00134	CcSEcCtD
Goserelin—Anxiety—Simvastatin—atherosclerosis	0.000939	0.00134	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—EDN1—atherosclerosis	0.000937	0.0031	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000932	0.00133	CcSEcCtD
Goserelin—Discomfort—Simvastatin—atherosclerosis	0.000931	0.00133	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—CCL5—atherosclerosis	0.00093	0.00308	CbGpPWpGaD
Goserelin—Nervous system disorder—Ezetimibe—atherosclerosis	0.000929	0.00133	CcSEcCtD
Goserelin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000928	0.00133	CcSEcCtD
Goserelin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000927	0.00133	CcSEcCtD
Goserelin—Anaemia—Pravastatin—atherosclerosis	0.000925	0.00132	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.000923	0.00306	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CX3CR1—atherosclerosis	0.000923	0.00306	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CASR—atherosclerosis	0.000923	0.00306	CbGpPWpGaD
Goserelin—Anorexia—Lovastatin—atherosclerosis	0.00092	0.00132	CcSEcCtD
Goserelin—Skin disorder—Ezetimibe—atherosclerosis	0.00092	0.00132	CcSEcCtD
Goserelin—Confusional state—Simvastatin—atherosclerosis	0.000911	0.0013	CcSEcCtD
Goserelin—Leukopenia—Niacin—atherosclerosis	0.00091	0.0013	CcSEcCtD
Goserelin—Urticaria—Rosuvastatin—atherosclerosis	0.000905	0.0013	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CX3CL1—atherosclerosis	0.000905	0.003	CbGpPWpGaD
Goserelin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000903	0.00129	CcSEcCtD
Goserelin—Oedema—Simvastatin—atherosclerosis	0.000903	0.00129	CcSEcCtD
Goserelin—Malaise—Pravastatin—atherosclerosis	0.000902	0.00129	CcSEcCtD
Goserelin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000901	0.00129	CcSEcCtD
Goserelin—Palpitations—Niacin—atherosclerosis	0.000898	0.00129	CcSEcCtD
Goserelin—Infection—Simvastatin—atherosclerosis	0.000897	0.00129	CcSEcCtD
Goserelin—Leukopenia—Pravastatin—atherosclerosis	0.000896	0.00128	CcSEcCtD
Goserelin—Cough—Niacin—atherosclerosis	0.000887	0.00127	CcSEcCtD
Goserelin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000884	0.00127	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HRH1—atherosclerosis	0.000882	0.00292	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00088	0.00126	CcSEcCtD
Goserelin—Insomnia—Lovastatin—atherosclerosis	0.000873	0.00125	CcSEcCtD
Goserelin—Cough—Pravastatin—atherosclerosis	0.000873	0.00125	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—EDNRA—atherosclerosis	0.00087	0.00288	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCR2—atherosclerosis	0.00087	0.00288	CbGpPWpGaD
Goserelin—Paraesthesia—Lovastatin—atherosclerosis	0.000867	0.00124	CcSEcCtD
Goserelin—Myalgia—Niacin—atherosclerosis	0.000865	0.00124	CcSEcCtD
Goserelin—Arthralgia—Niacin—atherosclerosis	0.000865	0.00124	CcSEcCtD
Goserelin—Hypertension—Pravastatin—atherosclerosis	0.000864	0.00124	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000863	0.00124	CcSEcCtD
Goserelin—Anorexia—Simvastatin—atherosclerosis	0.000861	0.00123	CcSEcCtD
Goserelin—Dyspnoea—Lovastatin—atherosclerosis	0.000861	0.00123	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000859	0.00123	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CNR2—atherosclerosis	0.000858	0.00284	CbGpPWpGaD
Goserelin—Insomnia—Ezetimibe—atherosclerosis	0.000857	0.00123	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.000853	0.00283	CbGpPWpGaD
Goserelin—Chest pain—Pravastatin—atherosclerosis	0.000852	0.00122	CcSEcCtD
Goserelin—Myalgia—Pravastatin—atherosclerosis	0.000852	0.00122	CcSEcCtD
Goserelin—Arthralgia—Pravastatin—atherosclerosis	0.000852	0.00122	CcSEcCtD
Goserelin—Paraesthesia—Ezetimibe—atherosclerosis	0.00085	0.00122	CcSEcCtD
Goserelin—Dyspepsia—Lovastatin—atherosclerosis	0.00085	0.00122	CcSEcCtD
Goserelin—Anxiety—Pravastatin—atherosclerosis	0.000849	0.00122	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—GHRL—atherosclerosis	0.000848	0.00281	CbGpPWpGaD
Goserelin—Dry mouth—Niacin—atherosclerosis	0.000846	0.00121	CcSEcCtD
Goserelin—Dyspnoea—Ezetimibe—atherosclerosis	0.000844	0.00121	CcSEcCtD
Goserelin—Discomfort—Pravastatin—atherosclerosis	0.000842	0.00121	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000841	0.00279	CbGpPWpGaD
Goserelin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000839	0.0012	CcSEcCtD
Goserelin—Decreased appetite—Lovastatin—atherosclerosis	0.000839	0.0012	CcSEcCtD
Goserelin—Dyspepsia—Ezetimibe—atherosclerosis	0.000834	0.00119	CcSEcCtD
Goserelin—Fatigue—Lovastatin—atherosclerosis	0.000832	0.00119	CcSEcCtD
Goserelin—Anaphylactic shock—Niacin—atherosclerosis	0.000829	0.00119	CcSEcCtD
Goserelin—Oedema—Niacin—atherosclerosis	0.000829	0.00119	CcSEcCtD
Goserelin—Constipation—Lovastatin—atherosclerosis	0.000826	0.00118	CcSEcCtD
Goserelin—Pain—Lovastatin—atherosclerosis	0.000826	0.00118	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000824	0.00273	CbGpPWpGaD
Goserelin—Confusional state—Pravastatin—atherosclerosis	0.000823	0.00118	CcSEcCtD
Goserelin—Decreased appetite—Ezetimibe—atherosclerosis	0.000823	0.00118	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000823	0.00118	CcSEcCtD
Goserelin—Asthenia—Rosuvastatin—atherosclerosis	0.000817	0.00117	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000817	0.00271	CbGpPWpGaD
Goserelin—Insomnia—Simvastatin—atherosclerosis	0.000817	0.00117	CcSEcCtD
Goserelin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000817	0.00117	CcSEcCtD
Goserelin—Oedema—Pravastatin—atherosclerosis	0.000817	0.00117	CcSEcCtD
Goserelin—Fatigue—Ezetimibe—atherosclerosis	0.000817	0.00117	CcSEcCtD
Goserelin—Shock—Niacin—atherosclerosis	0.000816	0.00117	CcSEcCtD
Goserelin—Infection—Pravastatin—atherosclerosis	0.000811	0.00116	CcSEcCtD
Goserelin—Paraesthesia—Simvastatin—atherosclerosis	0.000811	0.00116	CcSEcCtD
Goserelin—Pain—Ezetimibe—atherosclerosis	0.00081	0.00116	CcSEcCtD
Goserelin—Constipation—Ezetimibe—atherosclerosis	0.00081	0.00116	CcSEcCtD
Goserelin—Tachycardia—Niacin—atherosclerosis	0.000809	0.00116	CcSEcCtD
Goserelin—Pruritus—Rosuvastatin—atherosclerosis	0.000806	0.00115	CcSEcCtD
Goserelin—Skin disorder—Niacin—atherosclerosis	0.000806	0.00115	CcSEcCtD
Goserelin—Dyspnoea—Simvastatin—atherosclerosis	0.000805	0.00115	CcSEcCtD
Goserelin—Hyperhidrosis—Niacin—atherosclerosis	0.000802	0.00115	CcSEcCtD
Goserelin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000799	0.00115	CcSEcCtD
Goserelin—Feeling abnormal—Lovastatin—atherosclerosis	0.000796	0.00114	CcSEcCtD
Goserelin—Dyspepsia—Simvastatin—atherosclerosis	0.000795	0.00114	CcSEcCtD
Goserelin—Anorexia—Niacin—atherosclerosis	0.000791	0.00113	CcSEcCtD
Goserelin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00079	0.00113	CcSEcCtD
Goserelin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000789	0.00113	CcSEcCtD
Goserelin—Decreased appetite—Simvastatin—atherosclerosis	0.000785	0.00112	CcSEcCtD
Goserelin—Feeling abnormal—Ezetimibe—atherosclerosis	0.00078	0.00112	CcSEcCtD
Goserelin—Diarrhoea—Rosuvastatin—atherosclerosis	0.00078	0.00112	CcSEcCtD
Goserelin—Fatigue—Simvastatin—atherosclerosis	0.000779	0.00112	CcSEcCtD
Goserelin—Anorexia—Pravastatin—atherosclerosis	0.000778	0.00111	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—AGT—atherosclerosis	0.000778	0.00258	CbGpPWpGaD
Goserelin—Hypotension—Niacin—atherosclerosis	0.000775	0.00111	CcSEcCtD
Goserelin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000774	0.00111	CcSEcCtD
Goserelin—Constipation—Simvastatin—atherosclerosis	0.000772	0.00111	CcSEcCtD
Goserelin—Pain—Simvastatin—atherosclerosis	0.000772	0.00111	CcSEcCtD
Goserelin—Urticaria—Lovastatin—atherosclerosis	0.000767	0.0011	CcSEcCtD
Goserelin—Body temperature increased—Lovastatin—atherosclerosis	0.000763	0.00109	CcSEcCtD
Goserelin—Abdominal pain—Lovastatin—atherosclerosis	0.000763	0.00109	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000756	0.00108	CcSEcCtD
Goserelin—Dizziness—Rosuvastatin—atherosclerosis	0.000753	0.00108	CcSEcCtD
Goserelin—Urticaria—Ezetimibe—atherosclerosis	0.000752	0.00108	CcSEcCtD
Goserelin—Insomnia—Niacin—atherosclerosis	0.00075	0.00107	CcSEcCtD
Goserelin—Body temperature increased—Ezetimibe—atherosclerosis	0.000749	0.00107	CcSEcCtD
Goserelin—Abdominal pain—Ezetimibe—atherosclerosis	0.000749	0.00107	CcSEcCtD
Goserelin—Paraesthesia—Niacin—atherosclerosis	0.000745	0.00107	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—KNG1—atherosclerosis	0.000744	0.00247	CbGpPWpGaD
Goserelin—Feeling abnormal—Simvastatin—atherosclerosis	0.000744	0.00107	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000744	0.00107	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—AGTR1—atherosclerosis	0.00074	0.00245	CbGpPWpGaD
Goserelin—Dyspnoea—Niacin—atherosclerosis	0.000739	0.00106	CcSEcCtD
Goserelin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000739	0.00106	CcSEcCtD
Goserelin—Insomnia—Pravastatin—atherosclerosis	0.000739	0.00106	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CCL3—atherosclerosis	0.000738	0.00244	CbGpPWpGaD
Goserelin—Somnolence—Niacin—atherosclerosis	0.000737	0.00106	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—CCR2—atherosclerosis	0.000735	0.00243	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—EDNRA—atherosclerosis	0.000735	0.00243	CbGpPWpGaD
Goserelin—Paraesthesia—Pravastatin—atherosclerosis	0.000733	0.00105	CcSEcCtD
Goserelin—Dyspepsia—Niacin—atherosclerosis	0.00073	0.00105	CcSEcCtD
Goserelin—Dyspnoea—Pravastatin—atherosclerosis	0.000728	0.00104	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CCL4—atherosclerosis	0.000723	0.00239	CbGpPWpGaD
Goserelin—Decreased appetite—Niacin—atherosclerosis	0.000721	0.00103	CcSEcCtD
Goserelin—Dyspepsia—Pravastatin—atherosclerosis	0.000719	0.00103	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—F2—atherosclerosis	0.000719	0.00238	CbGpPWpGaD
Goserelin—Rash—Rosuvastatin—atherosclerosis	0.000718	0.00103	CcSEcCtD
Goserelin—Dermatitis—Rosuvastatin—atherosclerosis	0.000718	0.00103	CcSEcCtD
Goserelin—Urticaria—Simvastatin—atherosclerosis	0.000718	0.00103	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—GHRL—atherosclerosis	0.000716	0.00237	CbGpPWpGaD
Goserelin—Abdominal pain—Simvastatin—atherosclerosis	0.000714	0.00102	CcSEcCtD
Goserelin—Body temperature increased—Simvastatin—atherosclerosis	0.000714	0.00102	CcSEcCtD
Goserelin—Headache—Rosuvastatin—atherosclerosis	0.000714	0.00102	CcSEcCtD
Goserelin—Hypersensitivity—Lovastatin—atherosclerosis	0.000711	0.00102	CcSEcCtD
Goserelin—Decreased appetite—Pravastatin—atherosclerosis	0.00071	0.00102	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—UTS2—atherosclerosis	0.000709	0.00235	CbGpPWpGaD
Goserelin—Pain—Niacin—atherosclerosis	0.000709	0.00102	CcSEcCtD
Goserelin—Fatigue—Pravastatin—atherosclerosis	0.000704	0.00101	CcSEcCtD
Goserelin—Constipation—Pravastatin—atherosclerosis	0.000698	0.001	CcSEcCtD
Goserelin—Pain—Pravastatin—atherosclerosis	0.000698	0.001	CcSEcCtD
Goserelin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000698	0.000999	CcSEcCtD
Goserelin—Asthenia—Lovastatin—atherosclerosis	0.000693	0.000992	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—APOA4—atherosclerosis	0.000692	0.00229	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000684	0.00227	CbGpPWpGaD
Goserelin—Pruritus—Lovastatin—atherosclerosis	0.000683	0.000979	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CASR—atherosclerosis	0.00068	0.00225	CbGpPWpGaD
Goserelin—Asthenia—Ezetimibe—atherosclerosis	0.00068	0.000973	CcSEcCtD
Goserelin—Gastrointestinal pain—Niacin—atherosclerosis	0.000678	0.000971	CcSEcCtD
Goserelin—Nausea—Rosuvastatin—atherosclerosis	0.000677	0.000969	CcSEcCtD
Goserelin—Feeling abnormal—Pravastatin—atherosclerosis	0.000673	0.000964	CcSEcCtD
Goserelin—Pruritus—Ezetimibe—atherosclerosis	0.00067	0.00096	CcSEcCtD
Goserelin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000668	0.000956	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—EDNRA—atherosclerosis	0.000667	0.00221	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCR2—atherosclerosis	0.000667	0.00221	CbGpPWpGaD
Goserelin—Hypersensitivity—Simvastatin—atherosclerosis	0.000665	0.000953	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000665	0.0022	CbGpPWpGaD
Goserelin—Diarrhoea—Lovastatin—atherosclerosis	0.000661	0.000946	CcSEcCtD
Goserelin—Urticaria—Niacin—atherosclerosis	0.000659	0.000944	CcSEcCtD
Goserelin—Abdominal pain—Niacin—atherosclerosis	0.000656	0.000939	CcSEcCtD
Goserelin—Body temperature increased—Niacin—atherosclerosis	0.000656	0.000939	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—GHRL—atherosclerosis	0.00065	0.00215	CbGpPWpGaD
Goserelin—Urticaria—Pravastatin—atherosclerosis	0.000649	0.000929	CcSEcCtD
Goserelin—Asthenia—Simvastatin—atherosclerosis	0.000648	0.000928	CcSEcCtD
Goserelin—Diarrhoea—Ezetimibe—atherosclerosis	0.000648	0.000928	CcSEcCtD
Goserelin—Body temperature increased—Pravastatin—atherosclerosis	0.000645	0.000925	CcSEcCtD
Goserelin—Abdominal pain—Pravastatin—atherosclerosis	0.000645	0.000925	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—UTS2—atherosclerosis	0.000644	0.00213	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL2—atherosclerosis	0.000641	0.00212	CbGpPWpGaD
Goserelin—Pruritus—Simvastatin—atherosclerosis	0.000639	0.000915	CcSEcCtD
Goserelin—Dizziness—Lovastatin—atherosclerosis	0.000639	0.000915	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CCL4—atherosclerosis	0.000638	0.00211	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CNR2—atherosclerosis	0.000632	0.00209	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000632	0.00209	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—KNG1—atherosclerosis	0.000628	0.00208	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—EDN1—atherosclerosis	0.000627	0.00208	CbGpPWpGaD
Goserelin—Dizziness—Ezetimibe—atherosclerosis	0.000626	0.000897	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—AGTR1—atherosclerosis	0.000625	0.00207	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL5—atherosclerosis	0.000622	0.00206	CbGpPWpGaD
Goserelin—Diarrhoea—Simvastatin—atherosclerosis	0.000618	0.000885	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CX3CR1—atherosclerosis	0.000618	0.00205	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CASR—atherosclerosis	0.000618	0.00205	CbGpPWpGaD
Goserelin—Vomiting—Lovastatin—atherosclerosis	0.000614	0.000879	CcSEcCtD
Goserelin—Hypersensitivity—Niacin—atherosclerosis	0.000611	0.000875	CcSEcCtD
Goserelin—Rash—Lovastatin—atherosclerosis	0.000609	0.000872	CcSEcCtD
Goserelin—Dermatitis—Lovastatin—atherosclerosis	0.000608	0.000871	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CX3CL1—atherosclerosis	0.000606	0.00201	CbGpPWpGaD
Goserelin—Headache—Lovastatin—atherosclerosis	0.000605	0.000866	CcSEcCtD
Goserelin—Vomiting—Ezetimibe—atherosclerosis	0.000602	0.000863	CcSEcCtD
Goserelin—Hypersensitivity—Pravastatin—atherosclerosis	0.000602	0.000862	CcSEcCtD
Goserelin—Dizziness—Simvastatin—atherosclerosis	0.000597	0.000855	CcSEcCtD
Goserelin—Rash—Ezetimibe—atherosclerosis	0.000597	0.000855	CcSEcCtD
Goserelin—Dermatitis—Ezetimibe—atherosclerosis	0.000597	0.000855	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—APOA2—atherosclerosis	0.000596	0.00197	CbGpPWpGaD
Goserelin—Asthenia—Niacin—atherosclerosis	0.000595	0.000852	CcSEcCtD
Goserelin—Headache—Ezetimibe—atherosclerosis	0.000593	0.00085	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—HRH1—atherosclerosis	0.000591	0.00196	CbGpPWpGaD
Goserelin—Pruritus—Niacin—atherosclerosis	0.000587	0.00084	CcSEcCtD
Goserelin—Asthenia—Pravastatin—atherosclerosis	0.000586	0.000839	CcSEcCtD
Goserelin—Pruritus—Pravastatin—atherosclerosis	0.000578	0.000827	CcSEcCtD
Goserelin—Vomiting—Simvastatin—atherosclerosis	0.000574	0.000823	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CNR2—atherosclerosis	0.000574	0.0019	CbGpPWpGaD
Goserelin—Nausea—Lovastatin—atherosclerosis	0.000574	0.000822	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—KNG1—atherosclerosis	0.000571	0.00189	CbGpPWpGaD
Goserelin—Rash—Simvastatin—atherosclerosis	0.000569	0.000816	CcSEcCtD
Goserelin—Dermatitis—Simvastatin—atherosclerosis	0.000569	0.000815	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—UTS2—atherosclerosis	0.000569	0.00188	CbGpPWpGaD
Goserelin—Diarrhoea—Niacin—atherosclerosis	0.000567	0.000813	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—AGTR1—atherosclerosis	0.000567	0.00188	CbGpPWpGaD
Goserelin—Headache—Simvastatin—atherosclerosis	0.000566	0.00081	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000563	0.00187	CbGpPWpGaD
Goserelin—Nausea—Ezetimibe—atherosclerosis	0.000563	0.000806	CcSEcCtD
Goserelin—Diarrhoea—Pravastatin—atherosclerosis	0.000559	0.0008	CcSEcCtD
Goserelin—Dizziness—Niacin—atherosclerosis	0.000548	0.000786	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CX3CR1—atherosclerosis	0.000545	0.00181	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CASR—atherosclerosis	0.000545	0.00181	CbGpPWpGaD
Goserelin—Dizziness—Pravastatin—atherosclerosis	0.00054	0.000773	CcSEcCtD
Goserelin—Nausea—Simvastatin—atherosclerosis	0.000536	0.000768	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CX3CL1—atherosclerosis	0.000535	0.00177	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—EDN1—atherosclerosis	0.00053	0.00175	CbGpPWpGaD
Goserelin—Vomiting—Niacin—atherosclerosis	0.000527	0.000755	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—CCL5—atherosclerosis	0.000525	0.00174	CbGpPWpGaD
Goserelin—Rash—Niacin—atherosclerosis	0.000523	0.000749	CcSEcCtD
Goserelin—Dermatitis—Niacin—atherosclerosis	0.000522	0.000748	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—AGT—atherosclerosis	0.000521	0.00172	CbGpPWpGaD
Goserelin—Headache—Niacin—atherosclerosis	0.00052	0.000744	CcSEcCtD
Goserelin—Vomiting—Pravastatin—atherosclerosis	0.000519	0.000744	CcSEcCtD
Goserelin—Rash—Pravastatin—atherosclerosis	0.000515	0.000737	CcSEcCtD
Goserelin—Dermatitis—Pravastatin—atherosclerosis	0.000514	0.000737	CcSEcCtD
Goserelin—Headache—Pravastatin—atherosclerosis	0.000512	0.000733	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CNR2—atherosclerosis	0.000507	0.00168	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL8—atherosclerosis	0.000506	0.00168	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MMP3—atherosclerosis	0.000506	0.00167	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PRKCG—atherosclerosis	0.0005	0.00165	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL3—atherosclerosis	0.000494	0.00164	CbGpPWpGaD
Goserelin—Nausea—Niacin—atherosclerosis	0.000493	0.000706	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CCR2—atherosclerosis	0.000492	0.00163	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—EDNRA—atherosclerosis	0.000492	0.00163	CbGpPWpGaD
Goserelin—Nausea—Pravastatin—atherosclerosis	0.000485	0.000695	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—F2—atherosclerosis	0.000481	0.00159	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—EDN1—atherosclerosis	0.000481	0.00159	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GHRL—atherosclerosis	0.000479	0.00159	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL5—atherosclerosis	0.000477	0.00158	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOA4—atherosclerosis	0.000463	0.00154	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000462	0.00153	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PRKCG—atherosclerosis	0.000454	0.0015	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VWF—atherosclerosis	0.000452	0.0015	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOC3—atherosclerosis	0.000449	0.00149	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR2—atherosclerosis	0.000447	0.00148	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EDNRA—atherosclerosis	0.000447	0.00148	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LDLR—atherosclerosis	0.000446	0.00148	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000445	0.00147	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AGT—atherosclerosis	0.00044	0.00146	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL3—atherosclerosis	0.000436	0.00144	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GHRL—atherosclerosis	0.000435	0.00144	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL2—atherosclerosis	0.000429	0.00142	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL4—atherosclerosis	0.000427	0.00141	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—KNG1—atherosclerosis	0.000421	0.00139	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AGTR1—atherosclerosis	0.000418	0.00139	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NCF1—atherosclerosis	0.000417	0.00138	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—F2—atherosclerosis	0.000406	0.00135	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AGT—atherosclerosis	0.000399	0.00132	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOA2—atherosclerosis	0.000399	0.00132	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR2—atherosclerosis	0.000394	0.00131	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EDNRA—atherosclerosis	0.000394	0.00131	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CYBA—atherosclerosis	0.000392	0.0013	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000389	0.00129	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GHRL—atherosclerosis	0.000384	0.00127	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PLAT—atherosclerosis	0.000384	0.00127	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PARP1—atherosclerosis	0.000384	0.00127	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KNG1—atherosclerosis	0.000382	0.00127	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—UTS2—atherosclerosis	0.000381	0.00126	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AGTR1—atherosclerosis	0.00038	0.00126	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—F2—atherosclerosis	0.000369	0.00122	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CX3CR1—atherosclerosis	0.000365	0.00121	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CASR—atherosclerosis	0.000365	0.00121	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CX3CL1—atherosclerosis	0.000358	0.00119	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—EDN1—atherosclerosis	0.000354	0.00117	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CG—atherosclerosis	0.000353	0.00117	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCL5—atherosclerosis	0.000352	0.00117	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CNR2—atherosclerosis	0.000339	0.00112	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL8—atherosclerosis	0.000339	0.00112	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MMP3—atherosclerosis	0.000338	0.00112	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000338	0.00112	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KNG1—atherosclerosis	0.000337	0.00112	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AGTR1—atherosclerosis	0.000335	0.00111	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PRKCG—atherosclerosis	0.000334	0.00111	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL2—atherosclerosis	0.000329	0.00109	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PLG—atherosclerosis	0.000327	0.00108	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EDN1—atherosclerosis	0.000322	0.00107	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL5—atherosclerosis	0.000319	0.00106	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SOCS3—atherosclerosis	0.000309	0.00102	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PRKCG—atherosclerosis	0.000304	0.00101	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VWF—atherosclerosis	0.000302	0.001	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOC3—atherosclerosis	0.0003	0.000995	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LDLR—atherosclerosis	0.000299	0.000989	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP3—atherosclerosis	0.000299	0.000989	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF2—atherosclerosis	0.000297	0.000985	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AGT—atherosclerosis	0.000294	0.000975	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL3—atherosclerosis	0.000292	0.000966	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOB—atherosclerosis	0.000289	0.000956	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCL8—atherosclerosis	0.000286	0.000948	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EDN1—atherosclerosis	0.000284	0.000941	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL5—atherosclerosis	0.000282	0.000934	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NCF1—atherosclerosis	0.000279	0.000925	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LPL—atherosclerosis	0.000276	0.000913	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—F2—atherosclerosis	0.000272	0.000901	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRKCG—atherosclerosis	0.000268	0.000888	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AGT—atherosclerosis	0.000267	0.000885	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR2—atherosclerosis	0.000264	0.000874	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EDNRA—atherosclerosis	0.000264	0.000874	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CYBA—atherosclerosis	0.000263	0.00087	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SPP1—atherosclerosis	0.000261	0.000865	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00026	0.000862	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCL8—atherosclerosis	0.00026	0.000861	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLAT—atherosclerosis	0.000257	0.000852	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GHRL—atherosclerosis	0.000257	0.000852	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PARP1—atherosclerosis	0.000257	0.000852	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—F2—atherosclerosis	0.000247	0.000818	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PDGFB—atherosclerosis	0.000242	0.0008	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CG—atherosclerosis	0.000236	0.000783	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AGT—atherosclerosis	0.000236	0.000781	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LEP—atherosclerosis	0.000231	0.000765	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOE—atherosclerosis	0.000231	0.000765	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CAV1—atherosclerosis	0.000229	0.000758	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOA1—atherosclerosis	0.000228	0.000757	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KNG1—atherosclerosis	0.000226	0.000748	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AGTR1—atherosclerosis	0.000224	0.000743	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ESR1—atherosclerosis	0.000221	0.000731	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL2—atherosclerosis	0.00022	0.000729	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLG—atherosclerosis	0.000219	0.000724	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—F2—atherosclerosis	0.000218	0.000722	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CG—atherosclerosis	0.000208	0.000691	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SOCS3—atherosclerosis	0.000207	0.000686	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP3—atherosclerosis	0.0002	0.000662	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MAPK3—atherosclerosis	0.0002	0.000662	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF2—atherosclerosis	0.000199	0.000659	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—INS—atherosclerosis	0.000197	0.000654	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL2—atherosclerosis	0.000194	0.000643	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOB—atherosclerosis	0.000193	0.00064	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL8—atherosclerosis	0.000192	0.000635	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF1—atherosclerosis	0.000191	0.000632	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EDN1—atherosclerosis	0.00019	0.00063	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL5—atherosclerosis	0.000189	0.000625	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LPL—atherosclerosis	0.000185	0.000611	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SERPINE1—atherosclerosis	0.000181	0.000601	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCG—atherosclerosis	0.000179	0.000594	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SPP1—atherosclerosis	0.000175	0.000579	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL8—atherosclerosis	0.000174	0.000576	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOS3—atherosclerosis	0.000173	0.000573	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PDGFB—atherosclerosis	0.000162	0.000536	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AGT—atherosclerosis	0.000158	0.000523	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LEP—atherosclerosis	0.000155	0.000512	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOE—atherosclerosis	0.000155	0.000512	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL8—atherosclerosis	0.000154	0.000509	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CAV1—atherosclerosis	0.000153	0.000508	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOA1—atherosclerosis	0.000153	0.000506	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT1—atherosclerosis	0.000148	0.000491	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ESR1—atherosclerosis	0.000148	0.000489	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—atherosclerosis	0.000146	0.000484	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—F2—atherosclerosis	0.000146	0.000483	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CG—atherosclerosis	0.00014	0.000462	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—atherosclerosis	0.000139	0.00046	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NFKB1—atherosclerosis	0.000137	0.000455	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK8—atherosclerosis	0.000135	0.000447	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT1—atherosclerosis	0.000135	0.000446	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MAPK3—atherosclerosis	0.000134	0.000443	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—INS—atherosclerosis	0.000132	0.000438	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL2—atherosclerosis	0.00013	0.000431	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1—atherosclerosis	0.000128	0.000423	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—atherosclerosis	0.000125	0.000413	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STAT3—atherosclerosis	0.000123	0.000409	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SERPINE1—atherosclerosis	0.000121	0.000402	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK3—atherosclerosis	0.000118	0.000391	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOS3—atherosclerosis	0.000116	0.000384	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFB1—atherosclerosis	0.000114	0.000379	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL8—atherosclerosis	0.000103	0.00034	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT1—atherosclerosis	9.93e-05	0.000329	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—atherosclerosis	9.77e-05	0.000324	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—atherosclerosis	9.3e-05	0.000308	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NFKB1—atherosclerosis	9.2e-05	0.000305	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK8—atherosclerosis	9.04e-05	0.0003	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT1—atherosclerosis	9.02e-05	0.000299	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—atherosclerosis	8.62e-05	0.000286	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—atherosclerosis	8.35e-05	0.000277	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STAT3—atherosclerosis	8.27e-05	0.000274	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT1—atherosclerosis	7.96e-05	0.000264	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK3—atherosclerosis	7.9e-05	0.000262	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFB1—atherosclerosis	7.66e-05	0.000254	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—atherosclerosis	5.77e-05	0.000191	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT1—atherosclerosis	5.33e-05	0.000176	CbGpPWpGaD
